Search companies

Live

Tuesday, 17 November 2026 · 577 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Immuron CEO to present company update at Emerging Growth Conference

Immuron Limited (IMC) · Health care

IMC: $0.032 -13.51% · MC: $11M

Immuron said CEO Steven Lydeamore is presenting at the Emerging Growth Conference, with the accompanying presentation outlining its oral antibody platform and programs including Travelan and IMM-529. The supplied excerpt does not provide new financial or clinical updates.

Source announcements: 2026-10-28 16:11 to 2026-10-28 16:11 Sydney time
Story updated 2026-10-28 16:16 Sydney time
SourcesEmerging Growth Conference Presentation
Comments